» Articles » PMID: 30227960

High-Throughput Fitness Profiling of Zika Virus E Protein Reveals Different Roles for Glycosylation During Infection of Mammalian and Mosquito Cells

Overview
Journal iScience
Publisher Cell Press
Date 2018 Sep 20
PMID 30227960
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Zika virus (ZIKV) infection causes Guillain-Barré syndrome and severe birth defects. ZIKV envelope (E) protein is the major viral protein involved in cell receptor binding and entry and is therefore considered one of the major determinants in ZIKV pathogenesis. Here we report a gene-wide mapping of functional residues of ZIKV E protein using a mutant library, with changes covering every nucleotide position. By comparing the replication fitness of every viral mutant between mosquito and human cells, we identified that mutations affecting glycosylation display the most divergence. By characterizing individual mutants, we show that ablation of glycosylation selectively benefits ZIKV infection of mosquito cells by enhancing cell entry, whereas it either has little impact on ZIKV infection on certain human cells or leads to decreased infection through the entry factor DC-SIGN. In conclusion, we define the roles of individual residues of ZIKV envelope protein, which contribute to ZIKV replication fitness in human and mosquito cells.

Citing Articles

Comparison of Three Chimeric Zika Vaccine Prototypes Developed on the Genetic Background of the Clinically Proven Live-Attenuated Japanese Encephalitis Vaccine SA-14-2.

Song B, Frank J, Yun S, Julander J, Mason J, Polejaeva I Int J Mol Sci. 2025; 26(1.

PMID: 39796052 PMC: 11720029. DOI: 10.3390/ijms26010195.


Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus.

Garcia Jr G, Chakravarty N, Paiola S, Urena E, Gyani P, Tse C Cells. 2023; 12(19).

PMID: 37830597 PMC: 10572118. DOI: 10.3390/cells12192384.


Viral Protein Accumulation of Zika Virus Variants Links with Regulation of Innate Immunity for Differential Control of Viral Replication, Spread, and Response to Interferon.

Lu A, Gustin A, Newhouse D, Gale Jr M J Virol. 2023; 97(5):e0198222.

PMID: 37162358 PMC: 10231147. DOI: 10.1128/jvi.01982-22.


Replication-Deficient Zika Vector-Based Vaccine Provides Maternal and Fetal Protection in Mouse Model.

Garcia Jr G, Chakravarty N, Abu A, Jeyachandran A, Takano K, Brown R Microbiol Spectr. 2022; 10(5):e0113722.

PMID: 36169338 PMC: 9602260. DOI: 10.1128/spectrum.01137-22.


A Single Mutation at Position 120 in the Envelope Protein Attenuates Tembusu Virus in Ducks.

Yan D, Wang B, Shi Y, Ni X, Wu X, Li X Viruses. 2022; 14(3).

PMID: 35336854 PMC: 8951291. DOI: 10.3390/v14030447.


References
1.
Liu S, DeLalio L, Isakson B, Wang T . AXL-Mediated Productive Infection of Human Endothelial Cells by Zika Virus. Circ Res. 2016; 119(11):1183-1189. PMC: 5215127. DOI: 10.1161/CIRCRESAHA.116.309866. View

2.
Pokidysheva E, Zhang Y, Battisti A, Bator-Kelly C, Chipman P, Xiao C . Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell. 2006; 124(3):485-93. DOI: 10.1016/j.cell.2005.11.042. View

3.
DICK G, KITCHEN S, HADDOW A . Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952; 46(5):509-20. DOI: 10.1016/0035-9203(52)90042-4. View

4.
Shirato K, Miyoshi H, Goto A, Ako Y, Ueki T, Kariwa H . Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. J Gen Virol. 2004; 85(Pt 12):3637-3645. DOI: 10.1099/vir.0.80247-0. View

5.
Kuno G, Chang G . Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol. 2007; 152(4):687-96. DOI: 10.1007/s00705-006-0903-z. View